Atlas Trials

Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects

Clinical trial NCT05391724 · COMPLETED

Trial details

NCT number
NCT05391724
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2011-02-01
Primary completion
2011-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.